Re: Francesco Piva, Matteo Santoni, Marina Scarpelli, et al's Letter to the Editor re: Daniel M. Geynisman. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features. Eur Urol 2015;68:912-4

Eur Urol. 2017 Jan;71(1):e26. doi: 10.1016/j.eururo.2016.06.038. Epub 2016 Jul 11.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal*
  • Apoptosis Regulatory Proteins
  • Carcinoma, Renal Cell*
  • Humans
  • Kidney Neoplasms
  • Nivolumab

Substances

  • Antibodies, Monoclonal
  • Apoptosis Regulatory Proteins
  • Nivolumab